Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of “Real-world” Evidence

IMPORTANCE: Omalizumab is indicated for the management of chronic idiopathic urticaria (CIU) (also known as chronic spontaneous urticaria) in adolescents and adults with persistent hives not controlled with antihistamines. The effectiveness of omalizumab in the real-world management of CIU is largel...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Dermatol
Main Authors: Tharp, Michael D., Bernstein, Jonathan A., Kavati, Abhishek, Ortiz, Benjamin, MacDonald, Karen, Denhaerynck, Kris, Abraham, Ivo, Lee, Christopher S.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2018
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439579/
https://ncbi.nlm.nih.gov/pubmed/30427977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2018.3447
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker